NCT00356954View on ClinicalTrials.gov

NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization

PHASE4CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

April 30, 2006

Conditions

Kidney Failure

Interventions

DRUG

N-acetylcystein

DRUG

ascorbic acid

Trial Locations (1)

Unknown

Seoul National University Hospital , Cardiovascular Center, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER

NCT00356954 - NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization | Biotech Hunter | Biotech Hunter